Home Bioequivalence Bioavailability Study SOP for Handling Study Dropouts

SOP for Handling Study Dropouts

Bioequivalence Bioavailability Study By · · Comments off

Protocol for Managing Participant Withdrawals in BA/BE Studies

Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for handling participant dropouts and withdrawals from Bioavailability (BA) and Bioequivalence (BE) studies conducted in the pharmaceutical industry.

Scope

This SOP applies to all study personnel involved in participant recruitment, enrollment, and study conduct, including Investigators, Study Coordinators, and Clinical Research Associates (CRAs).

Responsibilities

  • The Investigator is responsible for documenting participant withdrawals, assessing the reasons for withdrawal, and determining the impact of withdrawals on study integrity and data analysis.
  • The Study Coordinator is responsible for notifying the sponsor and regulatory authorities of participant withdrawals, updating study records, and implementing strategies to mitigate the impact of withdrawals on study timelines and objectives.
  • The Clinical Research Associate (CRA) is responsible for monitoring participant enrollment and withdrawals, identifying trends or patterns in participant withdrawals, and reporting withdrawal-related issues to the sponsor.
See also  SOP for Use of Software and Electronic Data Capture

Procedure

  1. Document participant withdrawals promptly upon notification of withdrawal by the participant, study site personnel, or sponsor.
  2. Assess the reasons for participant withdrawals, including voluntary withdrawals, withdrawals due to adverse events, loss to follow-up, or protocol deviations.
  3. Determine the impact of participant withdrawals on study objectives, statistical analysis, and sample size calculations.
  4. Notify the sponsor and regulatory authorities of participant withdrawals as required by
study protocols, regulatory guidelines, and contractual agreements.
  • Update study records, including case report forms (CRFs), study databases, and regulatory submissions, to reflect participant withdrawals and the disposition of study data.
  • Implement strategies to mitigate the impact of participant withdrawals on study timelines and objectives, such as additional recruitment efforts, protocol amendments, or statistical adjustments.
  • Monitor participant withdrawals throughout the study conduct and identify any trends or patterns in participant withdrawals that may require further investigation or action.
  • Document all actions taken in response to participant withdrawals, including communication with participants, sponsors, and regulatory authorities, in study documentation and correspondence logs.

    • Abbreviations

    • SOP – Standard Operating Procedure
    • BA – Bioavailability
    • BE – Bioequivalence
    • CRA – Clinical Research Associate
    • CRF – Case Report Form

    Documents

    • Withdrawal Log
    • Communication Log
    • Protocol Deviation Report
    • Study Database

    Reference

    International Council for Harmonisation (ICH) E6 Good Clinical Practice guidelines and relevant regulatory guidelines for handling participant withdrawals in clinical research.

    SOP Version

    Version 1.0

    See also  SOP for Archiving Study Documents

    Related Posts

    SOP for Post-study Follow-up

    Protocol for Participant Monitoring after BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for conducting post-study follow-up activities with participants who have completed…

    SOP for Study Termination Procedures

    Protocol for Ending BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the termination of Bioavailability (BA) and Bioequivalence (BE) studies, ensuring proper…

    SOP for Handling Unblinding Procedures

    Protocol for Unmasking Treatment Allocation in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the handling of unblinding procedures in Bioavailability (BA)…

    SOP for Environmental Health and Safety in Clinical and Lab Settings

    Protocol for Ensuring Environmental Health and Safety in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for maintaining environmental health and safety standards…

    SOP for Stability Testing of Study Compounds

    Protocol for Assessing Stability of Investigational Compounds in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the stability testing of study compounds…

    SOP for Sample Re-analysis Procedures

    Protocol for Reassessment of Analytical Results in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the reanalysis of samples in Bioavailability (BA)…

    SOP for Cross-validation of Bioanalytical Methods

    Protocol for Verification of Bioanalytical Method Performance in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the cross-validation of bioanalytical methods used…

    SOP for Handling External Laboratory Results

    Protocol for Management of External Laboratory Data in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the handling and integration of external…

    SOP for Use of Software and Electronic Data Capture

    Protocol for Electronic Data Management in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the use of software and electronic data capture…

    SOP for Managing Confidentiality and Data Protection

    Protocol for Ensuring Confidentiality and Data Security in BA/BE Studies Purpose The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for managing confidentiality and data protection in…